The Federal Trade Commission has announced what it called a “landmark settlement” with Express Scripts over insulin pricing.
The agreement announced Wednesday includes sweeping changes to the Cigna PBM’s business practices, including no longer ...
The Federal Trade Commission has reached a landmark settlement with Express Scripts, one of the nation’s largest pharmacy ...
The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to ...
Pharmacy benefit managers, which set how drugs are covered by health insurance, have faced a decade of scrutiny from regulators and lawmakers over pricing.
Express Scripts, a pharmacy benefit manager and subsidiary of Cigna (CI), has reached a settlement with the FTC over ...
Cigna is hoping the settlement it reached with regulators paired with recent legislation will mollify calls to reform PBMs — ...
Express Scripts agreed to overhaul its business model, ensuring patients pay the lowest available price for medications and ...
According to Express Scripts, its new pharmacy benefits model, first announced in October 2025, could lower brand name ...
Feb 4 (Reuters) - Cigna Corp's Express Scripts has settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated antitrust and consumer protection laws, and agreed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results